Evidence map›Paper›PMID 37070555›Full record

ArticlePsychiatry and clinical neurosciences2023

Influence of cannabis use on incidence of psychosis in people at clinical high risk.

Lucy A Chester, Lucia R Valmaggia, Matthew J Kempton, Edward Chesney, Dominic Oliver, Emily P Hedges, Elise Klatsa, Daniel Stahl, Mark van der Gaag, Lieuwe de Haan and 14 more

Abstract read
In one paragraph

Article in Psychiatry and clinical neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Exploring causal mechanisms of psychosis risk.Neuroscience and biobehavioral reviews · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lucy A ChesterDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-7813-0281
Lucia R ValmaggiaDepartment of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0001-6099-8464
Matthew J KemptonDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0003-3541-9947
Edward ChesneyDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0003-2851-5252
Dominic OliverDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-8920-3407
Emily P HedgesDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0002-0543-4516
Elise KlatsaDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Daniel StahlDepartment of Biostatistics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0001-7987-6619
Mark van der GaagFaculty of Behavioural and Movement Sciences, Department of Clinical Psychology and EMGO+ Institute for Health and Care Research, VU University, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3525-6415
Lieuwe de HaanDepartment Early Psychosis, Amsterdam UMC, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3820-7926
Barnaby NelsonCentre for Youth Mental Health, University of Melbourne, Parkville, Victoria, Australia.ORCID https://orcid.org/0000-0002-6263-2332
Patrick McGorryCentre for Youth Mental Health, University of Melbourne, Parkville, Victoria, Australia.ORCID https://orcid.org/0000-0002-3789-6168
G Paul AmmingerCentre for Youth Mental Health, University of Melbourne, Parkville, Victoria, Australia.ORCID https://orcid.org/0000-0001-8969-4595
Anita Riecher-RösslerFaculty of Medicine, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0001-6361-8789
Erich StuderusDepartment of Psychology, Division of Personality and Developmental Psychology, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-4233-0182
Rodrigo BressanLiNC-Lab Interdisciplinar Neurociências Clínicas, Depto Psiquiatria, Escola Paulista de Medicina, Universidade Federal de São Paulo - UNIFESP, Sao Paulo, Brazil.ORCID https://orcid.org/0000-0002-0868-4449
Neus Barrantes-VidalDepartament de Psicologia Clínica i de la Salut, Universitat Autònoma de Barcelona, Fundació Sanitària Sant Pere Claver (Spain), Spanish Mental Health Research Network (CIBERSAM), Barcelona, Spain.ORCID https://orcid.org/0000-0002-8671-1238
Marie-Odile KrebsHôpital Sainte-Anne, C'JAAD, Service Hospitalo-Universitaire, Inserm U894, Institut de Psychiatrie (CNRS 3557), University Paris Descartes, Paris, France.ORCID https://orcid.org/0000-0002-4715-9890
Birte GlenthøjCentre for Neuropsychiatric Schizophrenia Research (CNSR) & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.ORCID https://orcid.org/0000-0003-3056-7262
Merete NordentoftMental Health Center Copenhagen and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Center Glostrup, Mental Health Services in the Capital Region of Copenhagen, University of Copenhagen, Kobenhavn, Denmark.ORCID https://orcid.org/0000-0003-4895-7023
Stephan RuhrmannDepartment of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.ORCID https://orcid.org/0000-0002-6022-2364
Gabriele SachsDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Wien, Austria.ORCID https://orcid.org/0000-0002-8359-9877
Philip McGuireDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID https://orcid.org/0000-0003-4381-0532
EU-GEI High Risk Study Group

Funding

Medical Research Council MR/J008915/1
6 · The paper itself

Abstract

aimsEvidence for case-control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this association remains controversial. The primary aim of the present study was to examine the association between cannabis use and the incidence of psychotic disorders in people at clinical high risk of psychosis. Secondary aims were to assess associations between cannabis use and the persistence of psychotic symptoms, and with functional outcome.

methodsCurrent and previous cannabis use were assessed in individuals at clinical high risk of psychosis (n = 334) and healthy controls (n = 67), using a modified version of the Cannabis Experience Questionnaire. Participants were assessed at baseline and followed up for 2 years. Transition to psychosis and persistence of psychotic symptoms were assessed using the Comprehensive Assessment of At-Risk Mental States criteria. Level of functioning at follow up was assessed using the Global Assessment of Functioning disability scale.

resultsDuring follow up, 16.2% of the clinical high-risk sample developed psychosis. Of those who did not become psychotic, 51.4% had persistent symptoms and 48.6% were in remission. There was no significant association between any measure of cannabis use at baseline and either transition to psychosis, the persistence of symptoms, or functional outcome.

conclusionsThese findings contrast with epidemiological data that suggest that cannabis use increases the risk of psychotic disorder.

Indexed as

CannabisMarijuana AbusePsychotic DisordersAdolescentAdultAge of OnsetFemaleHumansIncidenceMaleRisk FactorsSurveys and QuestionnairesYoung Adultclinical high-risklongitudinalpsychotic disorderssubstance useTHC

Identifiers

PMID37070555
PMCPMC7615575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.